Market Tracker

04/29 5:16pm ET

Merck & Co Inc (NYSE:MRK)

54.84
Delayed Data
As of 4:01pm ET
 -0.90 / -1.61%
Today’s Change
45.69
Today|||52-Week Range
61.70
+3.82%
Year-to-Date
Apple Drives Selloff on April's Last Trading Day
4:18pm / TheStreet.com
Healthcare Q1 Earnings Look Solid: ETFs to Benefit
Apr 25 / Zacks.com
Stocks Sell Off in Final Trading Day of April
12:12pm / TheStreet.com
Vaccine development needs global alliance
Apr 24 / FT.com
Gilead Sciences, Inc. Reports Disappointing Q1 Harvoni Sales
11:23am / MotleyFool.com
Vaccines are among big pharma's best-selling products
Apr 24 / FT.com
Gilead (GILD) Lags Q1 Earnings & Revenues, '16 View Intact
10:02am / Zacks.com
3 Things to Watch in Gilead Sciences, Inc.'s First-Quarter Results
Apr 23 / MotleyFool.com
9 Figures That Sum Up Gilead Sciences' First Quarter
Apr 28 / MotleyFool.com
16 Reasons to Buy Merck and Never Sell
Apr 19 / MotleyFool.com
AbbVie (ABBV) Beats on 1Q Earnings, Lowers View on Deal
Apr 28 / Zacks.com
Roche 'very optimistic' on prospects for new cancer drugs
Apr 19 / FT.com
3 Healthcare Stocks Billionaires Love Right Now
Apr 28 / MotleyFool.com
The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution
Apr 16 / MotleyFool.com
UnitedHealths Obamacare Changes to Affect Healthcare Sector
Apr 27 / GuruFocus News
Merck Offers Positive Data from Comparative Trial on Zepatier
Apr 14 / Zacks.com
Today's Top Performers In Health Care
Apr 27 / TheStreet.com
Drugmakers race to prescribe preventive migraine remedies
Apr 03 / FT.com
4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG
Apr 27 / Zacks.com
GSK returns to battle against cancer
Apr 03 / FT.com
5 Stocks With Bigger Dividends Than Merck & Co.
Apr 25 / MotleyFool.com